Category
PLB-1001 CAS:1440964-89-5

PLB-1001 CAS:1440964-89-5

Descriptio:

CPHIIndia Provide you with,Chemical properties,Mealting Point,Boiling point,Density,Formula,Molecular weight,Physical pr

Product Name PLB-1001
IUPAC Name 6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine
CAS No. 1440964-89-5
Synonyms Bozitinib
1440964-89-5
Vebreltinib
PLB-1001
APL-101
Bozitinib (PLB-1001)
Vebreltinib [USAN]
6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine
CBT-101
CBI-3103
2WZP8A9VFN
1,2,4-Triazolo(4,3-b)pyridazine, 6-(1-cyclopropyl-1H-pyrazol-4-yl)-3-(difluoro(6- fluoro-2-methyl-2H-indazol-5-yl)methyl)-
5-{[6-(1-cyclopropyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]difluoromethyl}-6-fluoro-2-methyl-2H-indazole
6-(1-Cyclopropyl-1H-pyrazol-4-yl)-3-(difluoro(6-fluoro-2-methyl-2H-indazol-5- yl)methyl)-1,2,4-triazolo(4,3-b)pyridazine
6-(1-Cyclopropyl-1H-pyrazol-4-yl)-3-(difluoro(6-fluoro-2-methyl-2H-indazol-5-yl)methyl)-[1,2,4]triazolo[4,3-b]pyridazine
UNII-2WZP8A9VFN
VEBRELTINIB [INN]
VEBRELTINIB [WHO-DD]
CHEMBL4650443
SCHEMBL15594471
GTPL11677
PLB1001
QHXLXUIZUCJRKV-UHFFFAOYSA-N
BDBM107096
EX-A5644
s6762
WHO 11677
AKOS040732634
MS-27454
HY-125017
CS-0088607
G16990
US9695175, 44
A937089
PLB-1001;T-101; APL-101; CBI-3103
Molecular Formula C20H15F3N8
Molecular Weight 424.4
InChI InChI=1S/C20H15F3N8/c1-29-9-11-6-14(15(21)7-17(11)27-29)20(22,23)19-26-25-18-5-4-16(28-31(18)19)12-8-24-30(10-12)13-2-3-13/h4-10,13H,2-3H2,1H3
InChI Key QHXLXUIZUCJRKV-UHFFFAOYSA-N
CPHIIndia Provide you with,Chemical properties,Mealting Point,Boiling point,Density,Formula,Molecular weight,Physical properties,Toxicity,Structure,Customs Code。